1. Home
  2. VBNK vs RAPP Comparison

VBNK vs RAPP Comparison

Compare VBNK & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VBNK
  • RAPP
  • Stock Information
  • Founded
  • VBNK 1980
  • RAPP 2022
  • Country
  • VBNK Canada
  • RAPP United States
  • Employees
  • VBNK N/A
  • RAPP N/A
  • Industry
  • VBNK Commercial Banks
  • RAPP
  • Sector
  • VBNK Finance
  • RAPP
  • Exchange
  • VBNK Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • VBNK 441.5M
  • RAPP 366.4M
  • IPO Year
  • VBNK 2021
  • RAPP 2024
  • Fundamental
  • Price
  • VBNK $11.63
  • RAPP $8.27
  • Analyst Decision
  • VBNK Strong Buy
  • RAPP Strong Buy
  • Analyst Count
  • VBNK 3
  • RAPP 5
  • Target Price
  • VBNK $19.00
  • RAPP $35.00
  • AVG Volume (30 Days)
  • VBNK 27.3K
  • RAPP 156.1K
  • Earning Date
  • VBNK 06-04-2025
  • RAPP 05-08-2025
  • Dividend Yield
  • VBNK 0.62%
  • RAPP N/A
  • EPS Growth
  • VBNK N/A
  • RAPP N/A
  • EPS
  • VBNK 0.89
  • RAPP N/A
  • Revenue
  • VBNK $75,813,751.00
  • RAPP N/A
  • Revenue This Year
  • VBNK $12.97
  • RAPP N/A
  • Revenue Next Year
  • VBNK $43.72
  • RAPP N/A
  • P/E Ratio
  • VBNK $15.69
  • RAPP N/A
  • Revenue Growth
  • VBNK N/A
  • RAPP N/A
  • 52 Week Low
  • VBNK $8.51
  • RAPP $6.43
  • 52 Week High
  • VBNK $18.38
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • VBNK 57.40
  • RAPP N/A
  • Support Level
  • VBNK $11.17
  • RAPP N/A
  • Resistance Level
  • VBNK $12.00
  • RAPP N/A
  • Average True Range (ATR)
  • VBNK 0.34
  • RAPP 0.00
  • MACD
  • VBNK 0.01
  • RAPP 0.00
  • Stochastic Oscillator
  • VBNK 61.86
  • RAPP 0.00

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: